The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2018
DOI: 10.1016/j.bbrc.2018.10.088
|View full text |Cite
|
Sign up to set email alerts
|

FFAR1-and FFAR4-dependent activation of Hippo pathway mediates DHA-induced apoptosis of androgen-independent prostate cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(16 citation statements)
references
References 24 publications
0
16
0
Order By: Relevance
“…An animal study showed that mimicking MYC overexpression induces PCa progression in PCa-model mice fed a diet high in saturated fatty acids [37]. However, suppression of PCa cell proliferation by intake of unsaturated fatty acids, such as eicosapentaenoic acids, docosahexaenoic acids, and α-linolenic acids, was demonstrated in an animal study and several in vitro experiments using human PCa cell lines [38][39][40][41].…”
Section: Fatmentioning
confidence: 99%
“…An animal study showed that mimicking MYC overexpression induces PCa progression in PCa-model mice fed a diet high in saturated fatty acids [37]. However, suppression of PCa cell proliferation by intake of unsaturated fatty acids, such as eicosapentaenoic acids, docosahexaenoic acids, and α-linolenic acids, was demonstrated in an animal study and several in vitro experiments using human PCa cell lines [38][39][40][41].…”
Section: Fatmentioning
confidence: 99%
“…The inhibition of Yap expression can activate breast cancer cell apoptosis; and in cardiac reperfusion injury, the Yap-Hippo pathway is inhibited and contributes to the progression of cardiac dysfunction by augmenting cardiomyocytes [66]. Moreover, in prostate cancer, Yap activation modulates docosahexaenoic acid-induced apoptosis in a manner dependent on the FFAR4 pathway [67]. Notably, the beneficial effects of Yap in brain tissues have also been widely explored.…”
Section: Discussionmentioning
confidence: 99%
“…YAP1/TAZ is generally activated by Gα12/13, Gα q/11 , and Gα i ; these G proteins are coupled with different GPCRs, including lysophosphatidic acid receptors, sphingosine1-phosphate (S1P) receptors, and protease-activated receptor 1 [73][74][75][76][77][78][79]. However, Gα s inhibits the Hippo-YAP1/TAZ pathway by other GPCRs, such as free fatty acid receptor 1/4 (FFAR1/4, also called as G-protein receptor 40/120 [GPR40/120]) [80][81][82]. Gα 12/13 , Gα q/11 , and Gα i mainly upregulate Ras homology family member A (RhoA)-Rho associated protein kinase (ROCK) signaling to catalyze the phosphorylation of its substrates, which affects YAP1/TAZ.…”
Section: Interaction Of Hippo-yap1/taz Signaling With the Gpcr Pathwaymentioning
confidence: 99%
“…YAP1/TAZ is generally activated by Gα 12/13 , Gα q/11 , and Gα i ; these G proteins are coupled with different GPCRs, including lysophosphatidic acid receptors, sphingosine1-phosphate (S1P) receptors, and protease-activated receptor 1 73 - 79 . However, Gα s inhibits the Hippo-YAP1/TAZ pathway by other GPCRs, such as free fatty acid receptor 1/4 (FFAR1/4, also called as G-protein receptor 40/120 [GPR40/120]) 80 - 82 .…”
Section: Interaction Of Hippo-yap1/taz Signaling With the Gpcr Pathwamentioning
confidence: 99%
See 1 more Smart Citation